Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | CGRP monoclonal antibodies & migraine management during COVID-19 pandemic

Stewart Tepper, MD, Professor of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH, discusses how to maintain migraine management during times of a global health crisis, including the experience from the United States and implications for the global COVID-19 pandemic. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).